General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Sonnet BioTherapeutics (NASDAQ:SONN) Shares Down 3.8% | news.google.com • |
Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy (CIPN) at the AACR 2024 Annual Meeting | accesswire.com • |
Why Is Sonnet BioTherapeutics (SONN) Stock Down 33% Today? | investorplace.com • |
7 F-Rated Biotech Stocks You Shouldn't Touch With a 10-Foot Pole | investorplace.com • |
Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today? | investorplace.com • |
Sonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology Conference | accesswire.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-08 | 2024-03 | 0 | N/A | N/A | N/A |
2024-02-14 | 2023-12 | 0 | -0.31 | N/A | N/A |
2023-12-18 | 2023-09 | 0 | N/A | N/A | N/A |
2023-08-14 | 2023-06 | 0 | -2.86 | N/A | N/A |
2023-05-10 | 2023-03 | 0 | -7.47 | N/A | N/A |
2023-02-13 | 2022-12 | 0 | -17.58 | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-05-16 | BHATT NAILESH | Director | 30.73K | Purchase |
2023-01-05 | CINI JOHN K | Officer | 40.27K | Stock Award(Grant) |
2022-12-13 | CROSS JOHN HARRY | Chief Financial Officer | 160.68K | Stock Award(Grant) |
2023-06-13 | DEXTER SUSAN | Chief Technology Officer | 33.67K | Purchase |
2023-05-29 | DYRNESS ALBERT D | Director | 28.96K | Purchase |
2022-12-08 | GRIFFITH DONALD J. CPA | Director | 10.30K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Sabby Management, LLC | 149.60K | 1.61M | 0.39% |
2023-06-29 | Renaissance Technologies, LLC | 13.36K | 144.01K | 0.03% |
2023-06-29 | Geode Capital Management, LLC | 7.70K | 83.01K | 0.02% |
2023-06-29 | Advisory Services Network, LLC | 3.25K | 35.00K | 0.01% |
2023-06-29 | State Street Corporation | 4.30K | 46.31K | 0.01% |
2023-06-29 | Two Sigma Securities, LLC | 3.10K | 33.36K | 0.01% |
Split | Date |
---|---|
1 : 22 | 2023-09-01 |
1 : 14 | 2022-09-19 |
1 : 26 | 2020-04-02 |
1 : 10 | 2017-05-19 |
1 : 2 | 2012-05-25 |
2 : 1 | 2011-03-23 |
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) announced that it will effect a 1-for-22 reverse stock split of its outstanding common stock. This will be effective for trading purposes as of the commencement of trading on Friday, September 1, 2023. Shares closed down 28% at $0.2.
What are you even still doing here… $CGC going to $1 tomorrow
When $6 SONN
It will reverse now $SONN
Go $ SONN
️️️️$COMS️️️️
️️️FRAUD ALERT ️️️
️️️DO NOT BUY️️️
️️FAKE PUMP IN PROGRESS️️
️️STAY AWAY FROM $COMS️️
️️️FRAUD ALERT ️️️
️️️DO NOT BUY️️️
️️FAKE PUMP IN PROGRESS️️
️️STAY AWAY FROM $COMS️️
$SONN GOING TO 3$ today!!!